Menu Back toV1-S4

14th DIA Japan Annual Meeting 2017

[V1-S4] The Changing Environment in the World and the Impact on the Pharmaceutical Industry

    Session Chair(s)
      Kihito  Takahashi, MD, PhD

      Kihito Takahashi, MD, PhD

      • Vice President and Senior Managing Director, Development & Medical Affairs Div.
      • GlaxoSmithKline K.K., Japan
    There was a worldwide impact event such as Brexit in EU and presidential election in US last year. This session is made up of 2 parts, the first part is Brexit. We would like to discuss the influence of Brexit for pharmaceutical companies in the world. On the other hand,” the international Summit of Heads of Medicines Regulatory Agencies” and” meeting of the International Coalition of Medicines Regulatory Authorities (ICMRA)” will convene for the first time in Japan, at the Kyoto in October and the representatives from a variety of countries and industries will discuss innovative technological developments and their practical applications, both current status and future expectations. In this session, we would like to confirm the movement in the world and discuss about the impacts and prospect in Japan.
      Peter  Bachmann

      The Brexit and the Possible Implications for Marketing Authorisation Holders

      Peter Bachmann

      • Deputy-Head, European Union and International Affairs
      • Federal Institute for Drugs and Medical Devices (BfArM), Germany
      Kazuhiko  Mori, MSc

      The Changing Environment in the World and the Impact on the Pharmaceutical Industry

      Kazuhiko Mori, MSc

      • Councilor for Pharmaceutical Affairs, Minister’s Secretariat
      • Ministry of Health, Labour and Welfare (MHLW), Japan
      Alberto  Grignolo, DIAFellow, PhD

      Alberto Grignolo, DIAFellow, PhD

      • Corporate VP PAREXEL Consulting
      • PAREXEL, United States
      Takuko  Sawada

      Takuko Sawada

      • Director of the Board, Sr Executive Officer, Sr VP, Corporate Strategy Division
      • Shionogi & Co., Ltd., Japan
      Tadaaki  Taniguchi, MD, PhD

      Tadaaki Taniguchi, MD, PhD

      • Executive Director and Strategic Officer, China Development, Emerging Market R&D
      • AstraZeneca K.K., Japan

Contact us

Please contact the DIA Japan office in Tokyo for further information.

Tel: +81-3-6214-0574
Fax: +81-3-3278-1313